Population pharmacokinetics of colistin: implications for clinical use for Gram-negative pathogens

Pachón Ibáñez, María Eugenia; Docobo Pérez, Fernando; Blanquero Bravo, Rafael; Garnacho Montero, José; Benítez Peña, Sandra; Dimopoulos, George; Rosso Fernández, Clara; Gutiérrez Pizarraya, Antonio; López Cortés, Luis Fernando; Cisneros Herreros, José Miguel

Ponencia

dc.creator	Pachón Ibáñez, María Eugenia	es
dc.creator	Docobo Pérez, Fernando	es
dc.creator	Blanquero Bravo, Rafael	es
dc.creator	Garnacho Montero, José	es
dc.creator	Benítez Peña, Sandra	es
dc.creator	Dimopoulos, George	es
dc.creator	Rosso Fernández, Clara	es
dc.creator	Gutiérrez Pizarraya, Antonio	es
dc.creator	López Cortés, Luis Fernando	es
dc.creator	Cisneros Herreros, José Miguel	es
dc.date.accessioned	2017-09-08T10:29:24Z
dc.date.available	2017-09-08T10:29:24Z
dc.date.issued	2016
dc.identifier.citation	Pachón Ibáñez, M.E., Docobo Pérez, F., Blanquero Bravo, R., Garnacho Montero, J., Benítez Peña, S., Dimopoulos, G.,...,Cisneros Herreros, J.M. (2016). Population pharmacokinetics of colistin: implications for clinical use for Gram-negative pathogens. En 26th European Congress of Clinical Microbiology and Infectious Diseases, Amsterdam.
dc.identifier.uri	http://hdl.handle.net/11441/64282
dc.description.abstract	The objective of this study was to characterize the pharmacokinetics of colistin methanesulphonate (CMS) and colistin in critically ill patients following the administration of a 4.5 MU CMS loading dose follow by 3MU CMS Q8. A population PK model and Monte Carlo simulation were used to calculate the probability of target attainment (PTA) against Acinetobacter baumannii and Pseudomonas aeruginosa by considering a range of MIC values seen in the clinic.	es
dc.format	application/pdf	es
dc.language.iso	eng	es
dc.relation.ispartof	26th European Congress of Clinical Microbiology and Infectious Diseases (2016).
dc.rights	Attribution-NonCommercial-NoDerivatives 4.0 Internacional	*
dc.rights.uri	http://creativecommons.org/licenses/by-nc-nd/4.0/	*
dc.title	Population pharmacokinetics of colistin: implications for clinical use for Gram-negative pathogens	es
dc.type	info:eu-repo/semantics/conferenceObject	es
dcterms.identifier	https://ror.org/03yxnpp24
dc.type.version	info:eu-repo/semantics/submittedVersion	es
dc.rights.accessRights	info:eu-repo/semantics/openAccess	es
dc.contributor.affiliation	Universidad de Sevilla. Departamento de Estadística e Investigación Operativa	es
dc.contributor.group	Universidad de Sevilla. FQM329: Optimización	es
dc.contributor.group	Universidad de Sevilla. CTS210: Adherencia Bacteriana a Nuevos Biomateriales	es
idus.format.extent	1 p.	es
dc.eventtitle	26th European Congress of Clinical Microbiology and Infectious Diseases	es
dc.eventinstitution	Amsterdam	es

Ficheros	Tamaño	Formato	Ver	Descripción
Population pharmacokinetics of ...	217.2Kb	[PDF]	Ver/Abrir

Este registro aparece en las siguientes colecciones

Ponencias (Estadística e Investigación Operativa)

Mostrar el registro sencillo del ítem

Excepto si se señala otra cosa, la licencia del ítem se describe como: Attribution-NonCommercial-NoDerivatives 4.0 Internacional